proteomics

Open Access
Integrated Proteomics Reveal ALDH1A1 as an Oncogenic Driver and Regulatory Hub in Hepatocellular Carcinoma
HANXUN YUE, ZENAN HU, GUOZHI WU, RENPENG LI, NA JIANG, YA ZHENG, YUPING WANG and YONGNING ZHOU

Cancer Genomics & Proteomics May 2026, 23 (3) 407-429; DOI: https://doi.org/10.21873/cgp.20582
Open Access
Proteomic Profiling Reveals HECTD4-dependent Regulation of Protein Ubiquitination and Signaling Pathways in Prostate Cancer
YASUO TAKASHIMA, MASAMI TANAKA, KENGO YOSHII, TOMOHITO YAGI, AYA MIYAGAWA-HAYASHINO and KEI TASHIRO

Cancer Genomics & Proteomics May 2026, 23 (3) 430-447; DOI: https://doi.org/10.21873/cgp.20583
Open Access
Proteomic Signatures of Cellular Reprogramming in Bladder Cancer: Insights into the Acquisition of Cancer Stem-like States and Phenotypic Plasticity
BENGI SU RUMEYSA BARLAK and BANU ISKENDER

Cancer Genomics & Proteomics March 2026, 23 (2) 300-321; DOI: https://doi.org/10.21873/cgp.20578
Open Access
Differential Proteomic Analysis of DEN-induced Hepatocellular Carcinoma in Male and Female Balb/c Mice Reveals Novel Sex-Specific Markers
SALMMA SALAMAH SALIHAH, MUHAMMAD TAHIR, BAREERA BIBI, RABIA SULTAN, MARTIN R. LARSEN, MUNAZZA RAZA MIRZA, SANA MAHMOOD, MUHAMMAD RIZWAN ALAM, JAMILA IQBAL, WILLIAM C. CHO and ASMA GUL

Cancer Genomics & Proteomics November 2025, 22 (6) 912-928; DOI: https://doi.org/10.21873/cgp.20540
Open Access
Lipid Metabolic Reprogramming During Progression to Castration-resistant Prostate Cancer Identified by Quantitative Proteomics
HYUNCHAE SIM, SUBIN BAE, CHAI WON PARK, SO YOUNG CHOI, KWANG-HYEON LIU, EUN HYE LEE, BUM SOO KIM, JAE-WOOK CHUNG, YUN-SOK HA, JUN NYUNG LEE, WONHWA LEE, TAE GYUN KWON and SANGKYU LEE

Cancer Genomics & Proteomics November 2025, 22 (6) 940-952; DOI: https://doi.org/10.21873/cgp.20548
Open Access
Serum Proteomic Signatures of Pregnancy-associated Breast Cancer
ANNA-MARIA KORAKITI, ELENI ZOGRAFOS, STAVROS C. PROIKAKIS, ALKISTIS-MARIA PAPATHEODORIDI, KLEONIKI APOSTOLIDOU, CONSTANTINOS G. ZOGRAFOS, DIMITRIOS MANIATIS, CHRISTOS STEFANOU, SPYRIDON MARINOPOULOS, CONSTANTINE DIMITRAKAKIS, GRIGORIOS XEPAPADAKIS, GEORGE T. TSANGARIS, MELETIOS-ATHANASIOS DIMOPOULOS and FLORA ZAGOURI

Cancer Genomics & Proteomics July 2025, 22 (4) 592-610; DOI: https://doi.org/10.21873/cgp.20524
Open Access
Particulate Matter 2.5 Induces FGFR1-mediated Integrin Switch to Promote Non-small Cell Lung Cancer Metastasis
NITHIKOON AKSORN, ZIN ZIN EI, KORRAKOD PETSRI, NARUMON PHAONAKROP, CHALERMPONG SAENJUM, SITTIRUK ROYTRAKUL and PITHI CHANVORACHOTE

Cancer Genomics & Proteomics July 2025, 22 (4) 632-653; DOI: https://doi.org/10.21873/cgp.20527
Open Access
Analysis of Protein–Protein Interactions Identifies NECTIN2 as a Target of N,N-Bis (5-Ethyl-2-hydroxybenzyl) Methylamine for Inhibition of Lung Cancer Metastasis
SUNISA THONGSOM, NITHIKOON AKSORN, KORRAKOD PETSRI, SITTIRUK ROYTRAKUL, NICHARAT SRIRATANASAK, WORAWAT WATTANATHANA and PITHI CHANVORACHOTE

Cancer Genomics & Proteomics September 2022, 19 (5) 624-635; DOI: https://doi.org/10.21873/cgp.20347
Open Access
Analysis of Protein–Protein Interactions Identifies NECTIN2 as a Target of N,N-Bis (5-Ethyl-2-hydroxybenzyl) Methylamine for Inhibition of Lung Cancer Metastasis
SUNISA THONGSOM, NITHIKOON AKSORN, KORRAKOD PETSRI, SITTIRUK ROYTRAKUL, NICHARAT SRIRATANASAK, WORAWAT WATTANATHANA and PITHI CHANVORACHOTE

Cancer Genomics & Proteomics September 2022, 19 (5) 624-635; DOI: https://doi.org/10.21873/cgp.20347
Open Access
Analysis of Protein–Protein Interactions Identifies NECTIN2 as a Target of N,N-Bis (5-Ethyl-2-hydroxybenzyl) Methylamine for Inhibition of Lung Cancer Metastasis
SUNISA THONGSOM, NITHIKOON AKSORN, KORRAKOD PETSRI, SITTIRUK ROYTRAKUL, NICHARAT SRIRATANASAK, WORAWAT WATTANATHANA and PITHI CHANVORACHOTE

Cancer Genomics & Proteomics September 2022, 19 (5) 624-635; DOI: https://doi.org/10.21873/cgp.20347

Main menu

User menu

Search

proteomics

Pages